Zentalis Pharmaceuticals ...
(ZNTL)
undefined
undefined%
At close: undefined
3.21
-1.08%
After-hours Jan 03, 2025, 04:01 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | 14.00K |
| Cost of Revenue | 1.39M | 1.43M | 544.00K | 160.00K | 111.00K | n/a |
| Gross Profit | -1.39M | -1.43M | -544.00K | -160.00K | -111.00K | 14.00K |
| Operating Income | -248.99M | -227.29M | -216.54M | -118.79M | -46.84M | -23.78M |
| Interest Income | n/a | 2.26K | 1.31K | 1.24K | 498.00K | 355.00K |
| Pretax Income | -276.89M | -221.30M | -164.56M | -118.10M | -46.36M | -23.43M |
| Net Income | -292.19M | -220.83M | -164.26M | -118.55M | -46.38M | -21.07M |
| Selling & General & Admin | 59.40M | 54.55M | 40.94M | 33.89M | 8.46M | 4.88M |
| Research & Development | 189.59M | 172.73M | 175.60M | 84.90M | 38.39M | 18.92M |
| Other Expenses | n/a | n/a | n/a | n/a | -16.00K | n/a |
| Operating Expenses | 252.55M | 227.29M | 216.54M | 118.79M | 46.84M | 23.80M |
| Interest Expense | n/a | 2.58M | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 253.94M | 227.29M | 216.54M | 118.79M | 46.84M | 23.80M |
| Income Tax | -601.00K | -469.00K | -297.00K | 444.00K | 15.00K | 4.00K |
| Shares Outstanding (Basic) | 65.41M | 52.86M | 42.69M | 41.04M | 35.88M | 18.06M |
| Shares Outstanding (Diluted) | 65.41M | 52.86M | 42.69M | 41.04M | 35.88M | 18.06M |
| EPS (Basic) | -4.47 | -4.18 | -3.85 | -2.89 | -1.29 | -1.17 |
| EPS (Diluted) | -4.47 | -4.18 | -3.85 | -2.89 | -1.29 | -1.17 |
| EBITDA | -275.50M | -219.87M | -164.01M | -117.94M | -46.73M | -23.73M |
| Depreciation & Amortization | 1.39M | 1.43M | 544.00K | 160.00K | 111.00K | 51.49K |